On September 3, 2021, IDUN Technologies AG announced it had closed a funding transaction. The company raised a total of CHF 2 million and received CHF 0.5 million as the final tranche. The transaction was led by returning investor MICA Ventures AG and WieInvest AG. Participating investors included returning investor Privilège Ventures, Joyance Partners, LLC, new investor CADFEM International AG, and Think Future Holding GmbH. The announcement provides the funding amounts, tranche detail, and investor list but does not disclose product, operating metrics, or use-of-proceeds information. IDUN Technologies develops accurate and comfortable sensors for wearable devices, centered on its Dryode product: a soft, flexible dry electrode for high-precision biopotential monitoring. The Dryode Kit, a reusable high-end electrode set targeting researchers, developers, and makers, is already available on the market. The company is a spin-off from ETH Zurich and currently has a team of ten employees. IDUN plans to expand its product portfolio with electrodes for scalp EEG and in-ear EEG. Financially, the startup recently closed a seed round with Sony and has taken an additional investment from Joyance Partners in the form of a convertible loan. Management is fundraising for a Series A round scheduled for early 2021 and intends to target VCs with neurotech, BCI, and international focus. IDUN Technologies develops and manufactures comfortable, preparation-free biopotential electrodes (Dryode) designed to deliver high-quality signals for brain and vital-sign monitoring in hearables, gaming and VR headsets. The company addresses technical challenges in skin-electrode interfaces and complex 3D structures to enable accurate, unobtrusive biometric wearables. Its Dryode material and physiology expertise are positioned as the first product in a pipeline toward continuous body monitoring for sports diagnostics, well-being and brain–computer interfaces. IDUN aims to be the interface between users' skin and everyday wearable devices to support future healthcare needs and the 'Internet of Humans.' The spin-off originates from ETH Zurich and has participated in Sony’s Startup Acceleration Program Europe. The company has stated it will scale its innovation and further explore product applications with new funding. IDUN Technologies develops silicon-based electrodes that conform to skin and remain conductive without gel for use in medical and non-medical wearable devices. The company was founded in 2017 as an ETH Zurich spinoff by Séverine Chardonnens and Simon Bachmann. It targets shortcomings of common electrodes—gel electrodes that dry out and irritate skin and dry electrodes that are painful and give poor signal quality. The silicon-based material aims to provide more accurate data analysis and higher wearing comfort. The article cites a large market opportunity, noting 300 million vital-sign monitoring devices were sold worldwide in 2017. IDUN plans to bring its first product to market later this year and will use the Venture Kick prize to accelerate industrialization.

Total raised

$4M

Funding rounds

4

Latest round

Seed

Latest activity

Sep 2021